17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome | Zendy

Renato Pasquali | Zendy; Laura Patton | Zendy; Patrizia Pocognoli | Zendy; Graçiela Estela Cognigni | Zendy; Alessandra Gambineri | Zendy

Open Access

17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome

Author(s) -

Renato Pasquali,

Laura Patton,

Patrizia Pocognoli,

Graçiela Estela Cognigni,

Alessandra Gambineri

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2007-0870

Subject(s) - hyperandrogenism , polycystic ovary , medicine , endocrinology , testosterone (patch) , gonadotropin releasing hormone agonist , buserelin , androgen , hormone , insulin resistance , insulin , luteinizing hormone , gonadotropin releasing hormone , agonist , receptor

The exaggerated 17-hydroxyprogesterone response to GnRH agonists, which reflects functional ovarian hyperandrogenism (FOH), is believed to be the prominent abnormality in women with polycystic ovary syndrome (PCOS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research